Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Wardell

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Pharmacology|October 1, 1971
Drug displacement from protein binding: isolation of a redistributional drug interaction in vivoE G McQueen, W M Wardell
Journal of Clinical Pharmacology|February 1, 1980
The measurement of therapeutic valueW M Wardell, J DiRaddo, M Weintraub
Clinical Pharmacology and Therapeutics|August 1, 1980
Development of new drugs originated and acquired by United States-owned pharmaceutical firms, 1963-1976W M Wardell, J DiRaddo, A G Trimble
Clinical Pharmacology and Therapeutics|June 1, 1983
New drug development during and after a period of regulatory change: clinical research activity of major United States pharmaceutical firms, 1958 to 1979M S May, W M Wardell, L Lasagna
Annals of the New York Academy of Sciences|January 1, 1981
New drug development in the changing health care environment: a panel discussionA Flanagan, R J Temple, W M Wardell
Clinical Pharmacology and Therapeutics|May 1, 1984
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safetyO M Bakke, W M Wardell, L Lasagna
Clinical Pharmacology and Therapeutics|October 1, 1982
New drug development by United States pharmaceutical firms with analyses of trends in the acquisition and origin of drug candidates, 1963-1979W M Wardell, M S May, A G Trimble
Annals of the New York Academy of Sciences|March 30, 1978
National rates and patterns of consumption of antihypertensive drugs in relation to their availability in the United States, the United Kingdom, Australia and New ZealandS R Petursson, W M Wardell, J P Curran
Clinical Pharmacology and Therapeutics|August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975W M Wardell, M Hassar, S N Anavekar, et al.
Regulatory Toxicology and Pharmacology : RTP|June 1, 1984
The development of self-originated new drugs by Swiss pharmaceutical firms, 1960-1980N Mattison, E Thomas, A G Trimble, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Pharmacology|October 1, 1971
Drug displacement from protein binding: isolation of a redistributional drug interaction in vivoE G McQueen, W M Wardell
Journal of Clinical Pharmacology|February 1, 1980
The measurement of therapeutic valueW M Wardell, J DiRaddo, M Weintraub
Clinical Pharmacology and Therapeutics|August 1, 1980
Development of new drugs originated and acquired by United States-owned pharmaceutical firms, 1963-1976W M Wardell, J DiRaddo, A G Trimble
Clinical Pharmacology and Therapeutics|June 1, 1983
New drug development during and after a period of regulatory change: clinical research activity of major United States pharmaceutical firms, 1958 to 1979M S May, W M Wardell, L Lasagna
Annals of the New York Academy of Sciences|January 1, 1981
New drug development in the changing health care environment: a panel discussionA Flanagan, R J Temple, W M Wardell
Clinical Pharmacology and Therapeutics|May 1, 1984
Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safetyO M Bakke, W M Wardell, L Lasagna
Clinical Pharmacology and Therapeutics|October 1, 1982
New drug development by United States pharmaceutical firms with analyses of trends in the acquisition and origin of drug candidates, 1963-1979W M Wardell, M S May, A G Trimble
Annals of the New York Academy of Sciences|March 30, 1978
National rates and patterns of consumption of antihypertensive drugs in relation to their availability in the United States, the United Kingdom, Australia and New ZealandS R Petursson, W M Wardell, J P Curran
Clinical Pharmacology and Therapeutics|August 1, 1978
The rate of development of new drugs in the United States, 1963 through 1975W M Wardell, M Hassar, S N Anavekar, et al.
Regulatory Toxicology and Pharmacology : RTP|June 1, 1984
The development of self-originated new drugs by Swiss pharmaceutical firms, 1960-1980N Mattison, E Thomas, A G Trimble, et al.
Pageof 5